Topical nanoencapsulated cannabidiol cream as an innovative strategy combating UV-A-induced nuclear and mitochondrial DNA injury: A pilot randomized clinical study

J Am Acad Dermatol. 2024 Nov;91(5):855-862. doi: 10.1016/j.jaad.2024.06.088. Epub 2024 Jul 25.

Abstract

Background: UV-A radiation contributes to photoaging/photocarcinogenesis by generating inflammation and oxidative damage. Current photoprotective strategies are limited by the availability/utilization of UV-A filters, highlighting an unmet need. Cannabidiol (CBD), having anti-inflammatory/antioxidant properties via regulation of nuclear erythroid 2-related factor, heme oxygenase 1, and peroxisome proliferator-activated receptor gamma, could potentially mitigate damage from UV-A exposure.

Objective/methods: This is a prospective, single-center, pilot clinical trial (NCT05279495). Nineteen participants applied nano-CBD (nCBD) or vehicle (VC) cream to randomized, blinded buttock sites twice daily for 14 days; then, the treated sites were irradiated with ≤3× UV-A minimal erythema dose. After 24 hours, punch biopsies were obtained for histology, immunohistochemistry, and real-time polymerase chain reaction.

Results: At 24 hours, 21% of participants had less observed erythema on CBD-treated skin than on VC skin. Histologically, nCBD-treated skin had reduced UV-A-induced epidermal hyperplasia than VC (P = .01). Immunohistochemistry detected reduced cytoplasmic/nuclear 8-oxoguanine glycosylase 1 staining in nCBD-treated skin compared with VC (P < .01). Quantitative mtDNA polymerase chain reaction demonstrated that UV-A-induced deletion of ND4 (proxy:4977 bp deletion; P = .003) and ND1 (proxy:3895 bp deletion; P = .002) was significantly reduced by in vivo nCBD treatment compared with VC.

Limitations: Small sample size is this study's limitation.

Conclusion: Topically applied nCBD cream reduced UV-A-induced formation of a frequent mutagenic nuclear DNA base lesion and protected against mtDNA mutations associated with UV-A-induced skin aging. To our knowledge, this trial is the first to identify UV-protective capacity of CBD-containing topicals in humans.

Keywords: 8-oxoguanine; UV-A; cannabidiol; cannabinoid; common deletion; mitochondrial DNA; mitochondrial mutation; photoaging; photodamage; photoprotection; reactive oxygen species.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Administration, Cutaneous
  • Adult
  • Aged
  • Cannabidiol* / administration & dosage
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • DNA Damage* / drug effects
  • DNA Damage* / radiation effects
  • DNA, Mitochondrial* / drug effects
  • Erythema / drug therapy
  • Erythema / etiology
  • Erythema / prevention & control
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nanocapsules
  • Pilot Projects
  • Prospective Studies
  • Skin / drug effects
  • Skin / pathology
  • Skin / radiation effects
  • Skin Aging / drug effects
  • Skin Aging / radiation effects
  • Skin Cream* / administration & dosage
  • Ultraviolet Rays* / adverse effects

Substances

  • Cannabidiol
  • DNA, Mitochondrial
  • Nanocapsules